Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/31/2010 | US7785717 An article comprising a substrate having an identifiable code pattern of fluorescent water soluble quantum dots of different colors operably bound to the substrate and have identifiable code pattern including encoded data |
08/31/2010 | US7785650 Water soluble, gelatin-free dip coatings for pharmaceutical solid dosage forms such as tablets comprising hydroxypropylmethyl cellulose and xanthan gum, carrageenan, and mixtures thereof, or hydroxypropylmethyl cellulose and castor oil or maltodextrin |
08/31/2010 | US7785640 Effervescent composition including cranberry extract |
08/31/2010 | US7785639 Flavonoid isolated from Pteridophyta, Thelypteris torresiana; anticancer |
08/31/2010 | US7785632 angiogenesis inhibitors; tetraiodothyroacetic acid conjugated to glycolide-lactide copolymer; binds cell surface receptor for thyroid hormone on integrin alpha at cell membrane level and does not activate signal transduction |
08/31/2010 | US7785631 Solid dose delivery vehicle and methods of making same |
08/31/2010 | US7785630 Mixture of active material in matrix of fatty alcohol or acid and solid hydrocarbon; microsphere |
08/31/2010 | US7785629 dissolving, suspending, recovering; androgen disorders |
08/31/2010 | US7785628 DL-lactide-ε-coprolactone copolymers |
08/31/2010 | US7785627 Daily dosage form comprising: controlled release core of an antihyperglycemic drug and an excipient.seal coat applied to the controlled release core; and immediate release thiazolidinedione coating over the seal coat; metformin hydrochloride and pioglitazone hydrochloride FDA Orange book listed patent |
08/31/2010 | US7785626 proton pump inhibitor and histamine H2 receptor antagonist; sustained release; for treatment of conditions associated with an excessive secretion of gastric acid; provides a suitable combination of a rapid onset and a long-lasting duration of the effect |
08/31/2010 | US7785625 Drug delivery, sustained release, time-release agents |
08/31/2010 | US7785624 aqueous pharmaceutical formulation comprising at least one latrunculin wherein the formulation does not contain a substantial amount of dimethyl sulfoxide; for treating glaucoma, inhibiting wound healing after trabeculectomy, and inhibiting angiogenesis. |
08/31/2010 | US7785623 Cosmetic encapsulated with lipid vesicules with charged surface; applying electric voltage |
08/31/2010 | US7785622 comprises fentanyl as active ingredient, pressure-sensitive adhesive base, and tackifier resin; pressure-sensitive adhesive base comprising polyisobutylene and styrene/isoprene/styrene block copolymer; easily produced, has long-term continuity, and is excellent in adhesion and conformability to skin |
08/31/2010 | US7785621 Oral compositions of fenretinide having increased bioavailability and methods of using the same |
08/31/2010 | US7785619 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
08/31/2010 | US7785617 Usable both as a scaffold for the growth of new tissue and as a delivery system or implant for pharmaceuticals, vaccines, hormones enzymes, and nutrients; high strength bonding between cell-compatible crosslinkers, e.g., biotin and/or avidin, and polymer, e.g., polyglycolic acid; diffusion; shaping |
08/31/2010 | US7785612 A vaccine comprising a polyglutamic acid coupled with phenylalanine ethyl ester as an adjuvant; biodegradable nanoparticles |
08/31/2010 | US7785602 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
08/31/2010 | US7785600 Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides |
08/31/2010 | US7785592 Stabilized liquid anti-RSV antibody formulations |
08/31/2010 | US7785578 Non-invasive ocular drug delivery |
08/31/2010 | US7785569 Measuring stomach discharging; analyzing emisison in breath; calibration |
08/31/2010 | US7785568 Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography |
08/31/2010 | US7785319 Method and apparatus for treating bodily tissues with medicinal substance |
08/31/2010 | US7785293 Infusion device and driving mechanism for same |
08/31/2010 | CA2673589C Method of drying biological material |
08/31/2010 | CA2578130C Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application |
08/31/2010 | CA2549383C Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof |
08/31/2010 | CA2473152C Orally dispersible pharmaceutical piribedil composition |
08/31/2010 | CA2462008C Systems, methods and apparatuses for manufacturing dosage forms |
08/26/2010 | WO2010096828A1 Multi-modality nanoparticles having optically responsive shape |
08/26/2010 | WO2010096820A1 Controlled release compositions comprising anti-cholinergic drugs |
08/26/2010 | WO2010096814A1 Controlled-release compositions comprising a proton pump inhibitor |
08/26/2010 | WO2010096806A1 Methods for loading contrast agents into a liposome |
08/26/2010 | WO2010096469A2 Fabrication of interconnected model vasculature |
08/26/2010 | WO2010096242A1 Ph-modulated formulations for pulmonary delivery |
08/26/2010 | WO2010096231A1 Policosanol nanoparticles |
08/26/2010 | WO2010096068A1 Controlled release budesonide minitablets |
08/26/2010 | WO2010096067A1 Controlled release budesonide minitablets |
08/26/2010 | WO2010095964A1 A method for amphiphilic drug loading in liposomes by ion gradient |
08/26/2010 | WO2010095875A2 Patch for treating constipation using crude drugs |
08/26/2010 | WO2010095840A2 Donepezil resin complex |
08/26/2010 | WO2010095578A1 Adhesive composition and adhesive tape |
08/26/2010 | WO2010095537A1 Transdermal preparation |
08/26/2010 | WO2010095494A1 Granules containing poorly soluble substance, tablet, and method for solubilizing poorly soluble substance |
08/26/2010 | WO2010095158A1 Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof |
08/26/2010 | WO2010095091A1 A process to make fusidic acid cream |
08/26/2010 | WO2010095090A1 A dermaceutical gel made using sodium fusidate & a process to make it |
08/26/2010 | WO2010095045A1 Amphiphilic compounds and self-assembling compositions made therefrom |
08/26/2010 | WO2010094996A1 Oral pharmaceutical composition for use in respiratory diseases |
08/26/2010 | WO2010094906A1 The stabilisation of proteins |
08/26/2010 | WO2010094806A2 A topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes |
08/26/2010 | WO2010094792A1 Emergency kit for producing a drug for nasal administration of opioids in the event of respiratory distress |
08/26/2010 | WO2010094731A2 Pharmaceutical composition for inhalation |
08/26/2010 | WO2010094624A1 Particles comprising drospirenone encapsulated in a polymer |
08/26/2010 | WO2010094623A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration |
08/26/2010 | WO2010094535A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives |
08/26/2010 | WO2010094471A1 Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation |
08/26/2010 | WO2010094218A1 Oral spray or aerosol of palonosetron |
08/26/2010 | WO2010062323A3 Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
08/26/2010 | WO2010052575A3 Ngna compositions and methods of use |
08/26/2010 | WO2010032880A3 Kinase inhibitory substances for cancer |
08/26/2010 | WO2009089011A8 Resveratrol formulations |
08/26/2010 | US20100217379 Implantable medical device comprising a pro-healing poly(ester-amide) |
08/26/2010 | US20100217287 Self-assembling fibrous networks |
08/26/2010 | US20100217045 Composition to enhance the bioavailability of curcumin |
08/26/2010 | US20100216804 Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents |
08/26/2010 | US20100216757 Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase |
08/26/2010 | US20100216692 Acidic Insulin Preparations Having Improved Stability |
08/26/2010 | US20100215958 Method for producing microparticles and the microparticles |
08/26/2010 | US20100215786 Morinda citrifolia enhanced lip treatment |
08/26/2010 | US20100215760 Intrinscially fluorescent carbon nanospheres and a process thereof |
08/26/2010 | US20100215759 Pharmaceutical compounds |
08/26/2010 | US20100215758 Effervescent nutritional and/or dietary supplement composition |
08/26/2010 | US20100215756 Pharmaceutical preparations containing highly volatile silicones |
08/26/2010 | US20100215754 Delivery System for Functional Compounds |
08/26/2010 | US20100215753 Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose |
08/26/2010 | US20100215752 Policosanol nanoparticles |
08/26/2010 | US20100215751 Methods and compositions for treating recurrent cancer |
08/26/2010 | US20100215750 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
08/26/2010 | US20100215748 Functionalized adhesive medical gel |
08/26/2010 | US20100215747 Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers |
08/26/2010 | US20100215746 Prevention of cisplatin induced deafness |
08/26/2010 | US20100215744 Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical |
08/26/2010 | US20100215743 Composition and drug delivery of bisphosphonates |
08/26/2010 | US20100215742 Drug active in neuropathic pain |
08/26/2010 | US20100215741 Pharmaceutical compounds |
08/26/2010 | US20100215740 Taste-masked orally disintegrating tablets of memantine hydrochloride |
08/26/2010 | US20100215739 Low dose topiramate / phentermine composition and methods of use thereof |
08/26/2010 | US20100215738 Prebiotic formulations and methods of use |
08/26/2010 | US20100215737 Combination pharmaceutical compositions |
08/26/2010 | US20100215736 Oral dosage form providing fast adsorption of drug |
08/26/2010 | US20100215735 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds |
08/26/2010 | US20100215734 Pharmaceutical compositions |
08/26/2010 | US20100215733 Device and method for reducing calorie intake |
08/26/2010 | US20100215732 Ingestible implement for weight control |
08/26/2010 | US20100215731 Method for improving cartilage repair and/or preventing cartilage degeneration in a joint |
08/26/2010 | US20100215730 Compositions for Nasal Administration of Phenothiazines |